SCHEMBL13697238

SCHEMBL13697238

COC(c1ccccc1)c1ccc(C)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MLKL Q8NB16 1/20 0.51
NPSR1 Q6W5P4 2/20 0.44
KDM4E B2RXH2 1/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
LMNA P02545 2/20 0.43
TSHR P16473 1/20 0.43
ALOX12 P18054 1/20 0.43
ACHE P22303 1/20 0.43
KEAP1 Q14145 1/20 0.43
NFE2L2 Q16236 1/20 0.43
PKM P14618 1/20 0.42
CHRNA7 P36544 1/20 0.42
IDO1 P14902 4/20 0.41
TDO2 P48775 4/20 0.41
RAB9A P51151 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
AURKA O14965 1/20 0.39
PTPN2 P17706 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23296602 0.91 IDO1 (0.46) MLKLNPSR1KDM4EKMT2ALMNA
SCHEMBL791847 0.91 MLKL (0.49) MLKLACHECHRNA7
SCHEMBL461448 0.88 IDO1 (0.47) NPSR1KDM4EKMT2ALMNATSHR
SCHEMBL11500414 0.84 LMNA (0.46) MLKLNPSR1KDM4EMEN1KMT2A
SCHEMBL12314500 0.84 AOC3 (0.46) MLKLNPSR1KDM4EMEN1KMT2A
SCHEMBL6751142 0.82 IDO1 (0.41) MLKLNPSR1KDM4EKMT2ALMNA
SCHEMBL9097250 0.82 SMN1; SMN2 (0.50) MLKLNPSR1IDO1TDO2SMN1; SMN2
SCHEMBL18388793 0.80 MLKL (0.42) MLKLNPSR1KDM4EMEN1KMT2A
SCHEMBL3482548 0.80 MEN1 (0.43) MLKLNPSR1KDM4EMEN1KMT2A
SCHEMBL14380217 0.80 MEN1 (0.43) MLKLNPSR1KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160083409-A1 METHOD FOR THE PREPARATION OF alpha-SUBSTITUTED ACRYL ALDEHYDES COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2016-03-24 US disclosed
EP-2118094-B1 GAMMA-LACTAMS FOR THE TREATMENT OF GLAUCOMA OR ELEVATED INTRAOCULAR PRESSURE ALLERGAN INC (US) 2013-04-17 EP disclosed
US-20090236229-A1 METHODS FOR PREPARING POLYMER COATINGS BY ELECTROCHEMICAL GRAFTING OF POLYMER BRUSHES, COMPOSITIONS PREPARED THEREBY AND COMPOSITIONS FOR PREPARING THE COATINGS THE UNIVERSITY OF HOUSTON SYSTEM (US) 2009-09-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160083409-A1 METHOD FOR THE PREPARATION OF alpha-SUBSTITUTED ACRYL ALDEHYDES ALDH1A1, ALDH3A1, ADH1A MLKL 4418/4885NPSR1 2591/4885KDM4E 856/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.